fMRI brain activation changes following treatment of a first bipolar manic episode.
fMRI brain activation changes following treatment of a first bipolar manic episode.
复制标题
DOI:
10.1111/bdi.12426
复制
发表时间:
2016-09
影响因子:
5.4
通讯作者:
Adler CM
中科院分区:
文献类型:
--
作者:
Strakowski SM;Fleck DE;Welge J;Eliassen JC;Norris M;Durling M;Komoroski RA;Chu WJ;Weber W;Dudley JA;Blom TJ;Stover A;Klein C;Strawn JR;DelBello MP;Lee JH;Adler CM
In this study, we tested the hypothesis that, with treatment, functional magnetic resonance imaging (fMRI) regional brain activation in first-episode mania would normalize, i.e., differences from health subjects would diminish over time, and would be associated with clinical remission status, potentially identifying neuroanatomic treatment response markers. Forty-two participants with bipolar I disorder were recruited during their first manic episode, pseudo-randomized to open-label lithium or quetiapine, and followed for eight weeks. fMRI scans were obtained at baseline and then after one and eight weeks of treatment, while participants performed a continuous performance task with emotional distracters. Healthy participants received fMRI scans at these same intervals. Specific region-of-interest (ROI) activations within prefrontal emotional networks were assessed as potential measures of treatment response. ROI data were reduced using exploratory factor analysis, which identified five factors that were organizationally consistent with functional anatomic models of human emotion modulation, replicating previous factor analyses in this population. One-half of the participants with bipolar disorder achieved remission by Week 8 and were contrasted with the other one-half that did not. Analyses demonstrated that, in the bipolar disorder group in general, treatment led to decreases in activation across brain regions toward healthy subject values. However, differences in activation changes were observed between subjects with bipolar disorder who did or did not achieve remission in subcortical and amygdala factors. These findings provide evidence for potential neuroanatomic treatment response markers in first-episode bipolar disorder.
登录
查看更多内容
影响因子:
11.3
作者:
Schneider MR;Klein CC;Weber W;Bitter SM;Elliott KB;Strakowski SM;Adler CM;DelBello MP
通讯作者:
DelBello MP
影响因子:
10.6
作者:
Hulvershorn, Leslie A.;Karne, Harish;Gunn, Abigail D.;Hartwick, Sarah L.;Wang, Yang;Hummer, Tom A.;Anand, Amit
通讯作者:
Anand, Amit
影响因子:
5.4
作者:
Chang, Kiki D.;Wagner, Christopher;Reiss, Allan
通讯作者:
Reiss, Allan
影响因子:
3.2
作者:
Lane, RD;Reiman, EM;Schwartz, GE
通讯作者:
Schwartz, GE
影响因子:
3.4
作者:
Passarotti, Alessandra M.;Sweeney, John A.;Pavuluri, Mani N.
通讯作者:
Pavuluri, Mani N.